Skip to main content
. 2013 Dec;4(4):388–396. doi: 10.3978/j.issn.2078-6891.2013.026

Table 1. Clinicopathological characteristics of colorectal PM/HM vs. PM only.

Characteristic PM/HM (n=11) PM only (n=22) P-value
Date of treatment (month-year) 0.8
    First treatment May-1999 Mar-1994
    Last treatment Sept-2010 Oct-2009
    Median treatment for the group Mar-2007 Jan-2008
Gender (n) 0.4
    Male 2 7
    Female 9 15
Mean age, years 60 57 1.0
Lymph node status (n) 0.5
    Positive 8 14
    Negative 3 6
    Not reported 0 2
Tumour differential grade (n) 0.06
    Well 0 2
    Moderate 10 13
    Poor 0 7
    Not reported 1 0
Mucinous tumour (n) 5 11 0.8
Tumour origin (n) 1.0
    Colon 9 18
    Rectum 2 4
Peritoneal cancer index
    Mean value (range) 13 [3-36] 13 [4-37] 1.0
Prior surgical score (n) 0.6
    0 2 2
    1 1 4
    2 3 9
    3 5 7
    Not reported 0 0
Synchronous disease (n) 0.8
    Yes 8 15
    No 3 7
IPC treatment (n) 1.0
    HIPEC [+EPIC] 7 [3] 14 [10]
    SPIC 4 8
    Median number of treatments 3 3 1.0
Preoperative chemotherapy (n) 0.1
    Yes 10 13
         1st line or neoadjuvant 10 13
         2nd line 2 2
         3rd line 1 1
    No 1 9
Adjuvant chemotherapy (n) 0.8
    Yes 4 7
    No 6 14
    Not reported 1 1

Abbreviations: HIPEC, hyperthermic intraperitoneal chemotherapy; SPIC, sequential postoperative intraperitoneal chemotherapy; EPIC, early postoperative intraperitoneal chemotherapy; PM, peritoneal metastases; HM, hepatic metastases